BofA Securities, Piper Sandler, and Leerink Partners acted as lead bookrunners for the offering. Stifel acted as a bookrunner and Lake Street Capital Markets acted as co-manager for the offering.

Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common ...

Sources include IPO ETF manager Renaissance Capital, and SEC filings ... Proposed NYSE symbol INR. Business: US oil and natural gas producer operating in the Utica and Marcellus Shales. Beta Bionics - ...

Thursday marked the Nasdaq Global Market debut of Beta Bionics, Inc. as its initial public offering (IPO) opened for trading ...

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...

Stable rates are the ones that have historically supported equity market gains, and a moderate rise in the 10-year Treasury ...

The high-beta investment style has continued to outperform low-volatility stocks. “This risk-on leadership has coincided with a multi-month rise in the 10-year U.S. Treasury yield (US10Y ...

Smart beta is a way of investing that combines the benefits of passive investing and the advantages of active investing strategies. It derives from the capital asset pricing model (CAPM ...

When is the Elden Ring Nightreign beta? The Lands Between beckons us once more for a standalone co-op adventure that introduces a roguelike loop into FromSoftware’s formula. Playtests are the ...